Intelligence / Healthtech / New Clinical Trials / Revision Skincare
Revision Skincare
12 Nov 2026: Trial registered · A Case Study to Assess a Brightening Skincare Regimen in Patients With Bothersome Skin Dark Spots. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 12 Nov 2026
- Title
- A Case Study to Assess a Brightening Skincare Regimen in Patients With Bothersome Skin Dark Spots
- Conditions
- Post - Inflammatory Hyperpigmentation, Pigmentation
- Phase
- Not applicable
- Study Type
- Interventional
- Status
- Completed
- Countries
- United States
- Country
- United States
- Reference
- NCT07933380
- Location
- United States
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Find the decision makers at Revision Skincare
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Revision Skincare in our registers.
More from United States
New Clinical Trials
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.